Answers are grounded in this paper and cite their sources.
Nanocarrier design for drug delivery shows effective adsorption of levodopa, suggesting promising applications.
This present work focuses on designing and identifying a probable nanocarrier for neurological drug-delivery applications. Silicon-doped graphdiyne (Si-GDY), exhibiting notable modulation in its electronic structure, was functionalized with amino acid derivatives (dopamine, octopamine, and tyramine) to evaluate molecular interactions. A systematic investigation of these nanocarriers was performed by using quantum chemical density functional theory (DFT). To explore the adsorption prospective of pristine and Si-TA-GDY nanocarriers toward the loading of levodopa (L-Dopa), an anti-Parkinson drug, through two different configurations (A and B). The adsorption (–26.811 kcal/mol) energy confirms stable equilibrium of L-Dopa on Si-TA-GDY (B). The lowest deformation energy (0.04892 kcal/mol) reveals minimal lattice strain. Si-TA-GDY@L-Dopa (A) shows energetically favorable adsorption via solvation stabilization (Δ E adsorp,solv ) in both water (–27.720 kcal/mol) and ethanol (–23.164 kcal/mol), indicating potential drug-carrier binding affinity. High solvation stabilization energies Δ E solv in water (–49.462 kcal/mol) and ethanol (–75.905 kcal/mol) demonstrate effective dielectric screening. Additionally, temperature-dependent thermochemical parameter analysis reveals spontaneous and exothermic adsorption dominated by enthalpic stabilization (–25.400 kcal/mol) and shows the highest firmness (Δ G = –13.783 kcal/mol) in Si-TA-GDY@L-Dopa (B). For the same system, the longer recovery time correlates with the higher NEB-derived desorption barrier (∼0.29 eV), enabling controlled drug release. Among all investigated complex structures, Si-doped GDY functionalized with tyramine exhibits the most favorable system toward L-Dopa at both configurations, suggesting that tyramine-functionalized Si-doped GDY serves as a promising candidate for future L-Dopa drug-delivery investigations for neurological disorder.
No takes yet. Share an insight, caveat, or question.
Ramesh et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: